IC
Journal
ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658
Informations de publication
Date de publication:
06 Oct 2020
06 Oct 2020
Historique:
received:
05
08
2020
accepted:
09
09
2020
entrez:
12
10
2020
pubmed:
13
10
2020
medline:
13
10
2020
Statut:
epublish
Résumé
Cancer is a major public health problem being one of the main causes of morbidity and mortality today. Recent advances in catalytic nanomedicine have offered new cancer therapies based on the administration of nanoparticles (NPs) of platinum (Pt) dispersed in catalytic mesoporous nanomaterials (titania, TiO
Identifiants
pubmed: 33043218
doi: 10.1021/acsomega.0c03759
pmc: PMC7542800
doi:
Types de publication
Journal Article
Langues
eng
Pagination
25381-25389Déclaration de conflit d'intérêts
The authors declare no competing financial interest.
Références
Chem Asian J. 2017 Jan 3;12(1):21-26
pubmed: 27911052
Nat Rev Cancer. 2017 Jan;17(1):20-37
pubmed: 27834398
Chem Commun (Camb). 2011 May 14;47(18):5232-4
pubmed: 21451853
Mater Sci Eng C Mater Biol Appl. 2017 Mar 1;72:650-658
pubmed: 28024634
J Pharmacopuncture. 2016 Jun;19(2):114-21
pubmed: 27386144
J Mater Sci Mater Med. 2015 Jan;26(1):5330
pubmed: 25577212
J Mater Sci Mater Med. 2015 Mar;26(3):148
pubmed: 25764083
Cancer Epidemiol. 2016 Sep;44 Suppl 1:S131-S140
pubmed: 27678315
Lancet. 2016 Oct 8;388(10053):1459-1544
pubmed: 27733281
BMC Cell Biol. 2009 Sep 17;10:65
pubmed: 19761582
Sci Transl Med. 2012 Aug 22;4(148):148rv9
pubmed: 22914624
Toxicology. 2014 Jan 6;315:86-91
pubmed: 24321264
N Engl J Med. 1999 Apr 15;340(15):1144-53
pubmed: 10202165
Nat Nanotechnol. 2007 Dec;2(12):751-60
pubmed: 18654426
Ann N Y Acad Sci. 1999 Nov 28;884:211-25
pubmed: 10842595
Cancer Res. 1993 Jan 15;53(2):417-22
pubmed: 8417833
Infect Immun. 2000 Apr;68(4):1928-33
pubmed: 10722584
Met Based Drugs. 2002;9(1-2):33-43
pubmed: 18475423
Mol Biol Cell. 2002 Nov;13(11):3915-29
pubmed: 12429835
Recent Pat Anticancer Drug Discov. 2006 Jan;1(1):1-22
pubmed: 18221023
Laryngoscope. 2006 Feb;116(2):292-6
pubmed: 16467722
Int J Nanomedicine. 2013;8:581-92
pubmed: 23413123
Pharmazie. 1987 Apr;42(4):245-8
pubmed: 3615556
Nanotechnology. 2010 Feb 26;21(8):85103
pubmed: 20101074
J Inorg Biochem. 2008 Jan;102(1):33-45
pubmed: 17689616
Drugs. 2003;63(15):1565-77
pubmed: 12887263
Biomed Res Int. 2015;2015:948501
pubmed: 26161423
BMC Clin Pharmacol. 2008 Sep 17;8:7
pubmed: 18796166
Nano Lett. 2010 Sep 8;10(9):3223-30
pubmed: 20726522
Lancet. 1997 Aug 23;350(9077):535-40
pubmed: 9284774
PLoS One. 2017 Sep 27;12(9):e0185554
pubmed: 28953974
Basic Clin Pharmacol Toxicol. 2010 Nov;107(5):868-76
pubmed: 22545969
Toxicology. 2006 May 1;222(1-2):103-13
pubmed: 16567030
Methods Enzymol. 2012;509:41-60
pubmed: 22568900
Toxicol Lett. 2008 Aug 28;180(3):222-9
pubmed: 18662754
Food Chem Toxicol. 2017 Jul;105:337-346
pubmed: 28465190
N Engl J Med. 1999 Apr 15;340(15):1137-43
pubmed: 10202164
Acta Biomater. 2008 Nov;4(6):2037-44
pubmed: 18640082
Inorg Chem. 2019 Dec 16;58(24):16676-16688
pubmed: 31790216
Sci Pharm. 2018 Jun 07;86(2):
pubmed: 29880783
Polymers (Basel). 2019 Apr 23;11(4):
pubmed: 31018506
Nat Rev Cancer. 2005 Mar;5(3):161-71
pubmed: 15738981
Nat Rev Cancer. 2002 May;2(5):389-96
pubmed: 12044015
Nano Lett. 2019 Aug 14;19(8):5674-5682
pubmed: 31361142
Oncol Rep. 2013 Apr;29(4):1285-92
pubmed: 23404427
Integr Med Res. 2017 Jun;6(2):141-148
pubmed: 28664137
Part Fibre Toxicol. 2010 Aug 21;7:22
pubmed: 20727197
Arch Toxicol. 1981 Apr;47(2):77-99
pubmed: 7271444
Biomaterials. 2013 Jul;34(23):5833-42
pubmed: 23642996